The Luterion group has established GMP-grade investigational medicinal product manufacturing capabilities supported by EU QP declaration. Its global development network is designed to support translational research, nonclinical development, clinical coordination, and future manufacturing expansion.
GMP-grade investigational medicinal product manufacturing capabilities supporting nonclinical and clinical supply through affiliated operations.
Manufacturing capabilities supported by EU Qualified Person (QP) declaration for investigational medicinal product supply.
Planned future manufacturing and GLP/GMP laboratory expansion supporting the group's regional development network.